368
Participants
Start Date
May 12, 2022
Primary Completion Date
November 1, 2024
Study Completion Date
December 16, 2024
Remaxol
Remaxol®, solution for infusions, by intravenous drop infusion in the dose of 400 ml/day, on everyday basis for 12 days
State Budget-Funded Health Institution Kryzhanovsky Krasnoyarsk Krai Clinical Cancer Centre, Krasnoyarsk
North-West Center of Evidence-Based Medicine, Saint Petersburg
Pirogov Clinic of High Medical Technologies, St. Petersburg State University, Saint Petersburg
St. Petersburg State Budget-Funded Health Institution City Clinical Cancer Centre, Saint Petersburg
Republican Clinical Cancer Centre, Ufa
POLYSAN Scientific & Technological Pharmaceutical Company
INDUSTRY